Asset Management One Co. Ltd. Sells 10,518 Shares of Globe Life Inc. $GL

Key Points

• Asset Management One trimmed its stake in Globe Life (NYSE:GL) by 78% in Q4, selling 10,518 shares and leaving 2,972 shares valued at about $421,000.
• Company insiders have been selling aggressively — EVP Michael Clay Majors sold 30,000 shares and CEO Frank M. Svoboda sold 12,500, with insiders disposing of 82,807 shares worth $12.04 million in the last 90 days.
• Globe Life raised its quarterly dividend to $0.33 (annualized $1.32, yield 0.9%), reported Q EPS of $3.43 versus a $3.46 estimate, and set FY2026 guidance of $15.40–$15.90 EPS while analysts' average price target sits at $172.67.

Asset Management One Co. Ltd. trimmed its position in Globe Life Inc. (NYSE:GL - Free Report) by 78.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,972 shares of the company's stock after selling 10,518 shares during the quarter. Asset Management One Co. Ltd.'s holdings in Globe Life were worth $421,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in GL. AQR Capital Management LLC lifted its holdings in Globe Life by 98.6% during the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company's stock valued at $174,340,000 after purchasing an additional 696,548 shares during the last quarter. Balyasny Asset Management L.P. bought a new stake in Globe Life during the 3rd quarter worth about $80,925,000. Westfield Capital Management Co. LP bought a new stake in Globe Life during the 3rd quarter worth about $61,569,000. Comerica Bank grew its holdings in Globe Life by 865.4% during the 3rd quarter. Comerica Bank now owns 152,662 shares of the company's stock worth $21,826,000 after acquiring an additional 136,849 shares during the last quarter. Finally, Qube Research & Technologies Ltd grew its holdings in Globe Life by 368.7% during the 3rd quarter. Qube Research & Technologies Ltd now owns 137,461 shares of the company's stock worth $19,653,000 after acquiring an additional 108,135 shares during the last quarter. Institutional investors own 81.61% of the company's stock.

Insider Buying and Selling at Globe Life

In related news, EVP Michael Clay Majors sold 30,000 shares of the business's stock in a transaction on Friday, February 6th. The shares were sold at an average price of $146.89, for a total transaction of $4,406,700.00. Following the transaction, the executive vice president directly owned 47,066 shares in the company, valued at approximately $6,913,524.74. The trade was a 38.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Frank M. Svoboda sold 12,500 shares of the business's stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the transaction, the chief executive officer owned 35,868 shares in the company, valued at approximately $5,192,969.04. The trade was a 25.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 82,807 shares of company stock valued at $12,041,286 in the last 90 days. Company insiders own 2.11% of the company's stock.

Globe Life Stock Performance

Shares of GL opened at $152.31 on Friday. Globe Life Inc. has a 12 month low of $111.13 and a 12 month high of $155.08. The stock has a market capitalization of $11.95 billion, a price-to-earnings ratio of 10.53 and a beta of 0.47. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.39. The firm has a fifty day simple moving average of $143.66 and a 200 day simple moving average of $139.51.

Globe Life (NYSE:GL - Get Free Report) last released its earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a return on equity of 21.30% and a net margin of 19.38%.The company had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the company posted $3.07 EPS. The business's revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Research analysts forecast that Globe Life Inc. will post 15.37 EPS for the current fiscal year.

Globe Life Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be issued a dividend of $0.33 per share. The ex-dividend date is Thursday, April 2nd. This is a positive change from Globe Life's previous quarterly dividend of $0.27. This represents a $1.32 dividend on an annualized basis and a yield of 0.9%. Globe Life's dividend payout ratio is presently 9.13%.

Analysts Set New Price Targets

A number of brokerages have commented on GL. Wells Fargo & Company increased their price objective on shares of Globe Life from $171.00 to $172.00 and gave the stock an "overweight" rating in a report on Friday, April 10th. Piper Sandler raised Globe Life to a "strong-buy" rating in a report on Thursday, April 2nd. Texas Capital raised Globe Life to a "strong-buy" rating in a report on Wednesday, March 18th. Weiss Ratings raised Globe Life from a "hold (c+)" rating to a "buy (b)" rating in a report on Monday, April 13th. Finally, Truist Financial boosted their price objective on Globe Life from $180.00 to $185.00 and gave the stock a "buy" rating in a report on Friday. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Globe Life presently has an average rating of "Buy" and an average price target of $172.67.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.